Max Chaffanet

8.4k total citations
105 papers, 4.4k citations indexed

About

Max Chaffanet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Max Chaffanet has authored 105 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 33 papers in Oncology and 32 papers in Genetics. Recurrent topics in Max Chaffanet's work include Genomic variations and chromosomal abnormalities (22 papers), Cancer Genomics and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (14 papers). Max Chaffanet is often cited by papers focused on Genomic variations and chromosomal abnormalities (22 papers), Cancer Genomics and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (14 papers). Max Chaffanet collaborates with scholars based in France, United States and Belgium. Max Chaffanet's co-authors include Daniel Birnbaum, José Adélaı̈de, Pascal Finetti, François Bertucci, Patrice Viens, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, Renaud Sabatier, Julien Mozziconacci and Arnaud Guillé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Max Chaffanet

105 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Max Chaffanet 2.4k 1.5k 1.0k 953 756 105 4.4k
Thoas Fioretos 2.5k 1.0× 981 0.7× 983 1.0× 2.5k 2.6× 1.1k 1.5× 153 5.6k
Cristina E. Tognon 2.0k 0.8× 980 0.7× 705 0.7× 691 0.7× 458 0.6× 81 3.6k
José A. Martínez-Climent 1.9k 0.8× 1.3k 0.9× 784 0.8× 952 1.0× 865 1.1× 135 4.5k
Scott J. Dylla 2.5k 1.0× 2.7k 1.8× 951 0.9× 652 0.7× 622 0.8× 36 4.7k
Juan C. Cigudosa 3.4k 1.4× 1.5k 1.0× 1.2k 1.2× 1.3k 1.4× 1.0k 1.3× 149 6.0k
Norihiko Kawamata 2.2k 0.9× 1.4k 0.9× 588 0.6× 745 0.8× 610 0.8× 96 4.0k
Raphaël Itzykson 3.5k 1.4× 2.0k 1.4× 1.2k 1.1× 2.9k 3.0× 1.5k 2.0× 139 6.7k
Nathalie Cervera 2.3k 0.9× 2.1k 1.4× 1.6k 1.6× 517 0.5× 428 0.6× 32 4.2k
Antoninus Soosaipillai 1.3k 0.5× 1.1k 0.7× 604 0.6× 877 0.9× 1.8k 2.4× 91 3.6k
Claudia Scholl 2.7k 1.1× 688 0.5× 674 0.7× 2.0k 2.1× 676 0.9× 72 4.2k

Countries citing papers authored by Max Chaffanet

Since Specialization
Citations

This map shows the geographic impact of Max Chaffanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Chaffanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Chaffanet more than expected).

Fields of papers citing papers by Max Chaffanet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Chaffanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Chaffanet. The network helps show where Max Chaffanet may publish in the future.

Co-authorship network of co-authors of Max Chaffanet

This figure shows the co-authorship network connecting the top 25 collaborators of Max Chaffanet. A scholar is included among the top collaborators of Max Chaffanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Chaffanet. Max Chaffanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillé, Arnaud, José Adélaı̈de, Pascal Finetti, et al.. (2024). A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing. Briefings in Bioinformatics. 26(1). 2 indexed citations
2.
Adélaı̈de, José, Thi Khanh Le, Pascal Finetti, et al.. (2023). ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics. 15(7). 1930–1930. 3 indexed citations
3.
Dion, Camille, David Hirst, Leslie Caron, et al.. (2023). In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype. Nucleic Acids Research. 51(14). 7269–7287. 3 indexed citations
4.
Velázquez, Carolina, Béatrice Orsetti, José Adélaı̈de, et al.. (2023). BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Frontiers in Oncology. 13. 1125021–1125021. 5 indexed citations
5.
Crompot, Emerence, Pascal Finetti, Arnaud Guillé, et al.. (2022). Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate. Molecular Cancer Therapeutics. 21(7). 1227–1235. 39 indexed citations
6.
Nonneville, Alexandre de, Sébastien Salas, François Bertucci, et al.. (2022). TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO Molecular Medicine. 14(10). e15859–e15859. 27 indexed citations
7.
Sabatier, Renaud, Cécile Vicier, Séverine Garnier, et al.. (2022). Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular Oncology. 16(10). 2057–2070. 5 indexed citations
8.
Guillé, Arnaud, Pierre‐Emmanuel Colombo, José Adélaı̈de, et al.. (2022). Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine. 12(5). 655–655. 2 indexed citations
9.
Bertucci, François, Pascal Finetti, Arnaud Guillé, et al.. (2019). NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers. Molecular Oncology. 14(3). 504–519. 27 indexed citations
10.
Finetti, Pascal, Arnaud Guillé, José Adélaı̈de, et al.. (2014). ESPL1 is a candidate oncogene of luminal B breast cancers. Breast Cancer Research and Treatment. 147(1). 51–59. 41 indexed citations
11.
Letessier, A, Daniel Birnbaum, Michelle Debatisse, & Max Chaffanet. (2011). La pauvreté en sites d’initiation de la réplication rend-elle fragile certaines régions du génome ?. médecine/sciences. 27(8-9). 707–709. 5 indexed citations
12.
Sircoulomb, Fabrice, Ismahane Bekhouche, Pascal Finetti, et al.. (2010). Genome profiling of ERBB2-amplified breast cancers. BMC Cancer. 10(1). 539–539. 123 indexed citations
13.
Finetti, Pascal, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, et al.. (2008). Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis. Cancer Research. 68(3). 767–776. 96 indexed citations
14.
Adélaı̈de, José, Pascal Finetti, Ismahane Bekhouche, et al.. (2007). Integrated Profiling of Basal and Luminal Breast Cancers. Cancer Research. 67(24). 11565–11575. 221 indexed citations
15.
Etienne, Anne, Nadine Carbuccia, José Adélaı̈de, et al.. (2007). Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes. Cancer Genetics and Cytogenetics. 176(1). 80–88. 20 indexed citations
16.
Ginestier, Christophe, Nathalie Cervera, Pascal Finetti, et al.. (2006). Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers. Clinical Cancer Research. 12(15). 4533–4544. 107 indexed citations
17.
Chin, Suet‐Feung, Christophe Ginestier, Valérie‐Jeanne Bardou, et al.. (2004). A Recurrent Chromosome Breakpoint in Breast Cancer at the NRG1 / Neuregulin 1 / Heregulin Gene. Cancer Research. 64(19). 6840–6844. 73 indexed citations
18.
Mugneret, Francine, Max Chaffanet, Marc Maynadié, et al.. (2000). The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene . SHORT REPORT. British Journal of Haematology. 111(2). 647–649. 24 indexed citations
19.
Wang, Xiao-Zhong, Nathalie Conte, Max Chaffanet, et al.. (1999). γ-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Oncogene. 18(41). 5718–5721. 40 indexed citations
20.
Chaffanet, Max, et al.. (1989). Expression of the preproenkephalin A gene in tumor cells and brain glioma: A Northern and in situ hybridization study. Neuropeptides. 13(2). 133–138. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thoas Fioretos Breakdown of academic impact, for papers by Cristina E. Tognon Breakdown of academic impact, for papers by José A. Martínez-Climent Breakdown of academic impact, for papers by Scott J. Dylla Breakdown of academic impact, for papers by Juan C. Cigudosa Breakdown of academic impact, for papers by Norihiko Kawamata Breakdown of academic impact, for papers by Raphaël Itzykson Breakdown of academic impact, for papers by Nathalie Cervera Breakdown of academic impact, for papers by Antoninus Soosaipillai Breakdown of academic impact, for papers by Claudia Scholl
Rankless by CCL
2026